Published in Atherosclerosis on May 01, 1994
The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta (2011) 1.03
Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes. Eur J Hum Genet (2009) 0.82
Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure. Clin Exp Nephrol (2006) 0.75
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med (1998) 3.97
Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. I. Arterographic correlations. Circulation (1973) 2.99
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
[Unexplained non-cardiac chest pain; its prevalence and natural course]. Ned Tijdschr Geneeskd (1998) 2.64
Magnetic resonance imaging in coronary artery disease. Circulation (1995) 2.57
Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II. Ventriculographic and other correlations. Circulation (1973) 2.17
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11
Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction. Eur Heart J (1997) 2.06
Risk factors and anti-HBc reactivity among first time blood donors. Vox Sang (1997) 1.94
Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. Eur Heart J (2000) 1.81
Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. N Engl J Med (1985) 1.74
Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The Rotterdam Study. Arthritis Rheum (1996) 1.72
Natural history of obstructive coronary artery disease: ten-year study of 601 nonsurgical cases. Prog Cardiovasc Dis (1978) 1.70
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group. Circulation (2000) 1.65
Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy. Eur Heart J (1996) 1.58
Regression of coronary artery obstructions demonstrated by coronary arteriography. Eur J Cardiol (1976) 1.57
A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res (1996) 1.54
Vertebral deformities and functional impairment in men and women. J Bone Miner Res (1997) 1.53
The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients. Circulation (1981) 1.52
Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation (1996) 1.49
Catheter sizes for quantitative coronary arteriography. Cathet Cardiovasc Diagn (1994) 1.44
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS) Circulation (1997) 1.42
The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. Bone Miner (1994) 1.41
Raman microspectroscopy of human coronary atherosclerosis: biochemical assessment of cellular and extracellular morphologic structures in situ. Cardiovasc Pathol (2001) 1.40
Micro stent, quantitative coronary angiography, and procedural results. Cathet Cardiovasc Diagn (1996) 1.39
[A patient with hypocalcemia: an experiment of nature and culture]. Ned Tijdschr Geneeskd (1993) 1.38
Micro stent I, initial results, and six months follow-up by quantitative coronary angiography. Cathet Cardiovasc Diagn (1998) 1.37
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
Prediction of osteoporotic fractures in the general population by a fracture risk score. A 9-year follow-up among middle-aged women. Am J Epidemiol (1990) 1.34
Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) (2000) 1.30
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis (2007) 1.28
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb (1991) 1.26
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation (1997) 1.22
Actual outcome in infants with congenital diaphragmatic hernia: the role of a standardized postnatal treatment protocol. Fetal Diagn Ther (2011) 1.20
Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol (2000) 1.20
B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol (1998) 1.18
Diagnosis of human coronary atherosclerosis by morphology-based Raman spectroscopy. Cardiovasc Pathol (2001) 1.18
Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation (1994) 1.17
Mitochondria with loosely and tightly coupled oxidative phosphorylation in skeletal muscle. Biochim Biophys Acta (1968) 1.16
Vertebral deformities as predictors of non-vertebral fractures. BMJ (1994) 1.16
Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr (1991) 1.15
Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. Bone (1996) 1.14
Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry (2005) 1.13
Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. Diabetologia (2006) 1.13
Myocardial involvement in acromegaly. Int J Cardiol (1984) 1.13
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis (1999) 1.12
Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee. J Clin Invest (1997) 1.12
Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol (1997) 1.11
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol (1995) 1.10
Quantitation of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J (1993) 1.10
Clinical course of patients with normal, and slightly or moderately abnormal coronary arteriograms. A follow-up study on 500 patients. Circulation (1973) 1.10
Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology (1991) 1.10
On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun (1980) 1.09
Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol (1996) 1.09
On fatty acid activation in rat liver mitochondria. Biochim Biophys Acta (1969) 1.09
Acute myocardial infarction without obstructive coronary artery disease demonstrated by selective cinearteriography. Br Heart J (1971) 1.08
The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia. J Intern Med (1990) 1.08
Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ (1996) 1.05
In vivo determination of the molecular composition of artery wall by intravascular Raman spectroscopy. Anal Chem (2000) 1.05
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia (2005) 1.04
Fifteen year survival study of patients with obstructive coronary artery disease. Circulation (1983) 1.04
Heart rate and heart rate variability as indexes of sympathovagal balance. Am J Physiol (1994) 1.03
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation (1995) 1.03
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res (1999) 1.02
Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler Thromb (1992) 1.02
NF2 status of meningiomas is associated with tumour localization and histology. J Pathol (2001) 1.02
Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam Study. J Bone Miner Res (1994) 1.01
The importance of high-frequency paced breathing in spectral baroreflex sensitivity assessment. J Hypertens (2000) 1.00
The effect of fasting on the acylation of carnitine and glycerophosphate in rat liver subcellular fractions. Biochim Biophys Acta (1974) 0.99
Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease. Chest (1989) 0.98
Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol (1992) 0.98
New developments in pharmacologic stress imaging. Am Heart J (1992) 0.97
In vivo uptake of human and rat low density and high density lipoprotein by parenchymal and nonparenchymal cells from rat liver. Biochim Biophys Acta (1978) 0.97
Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial. Heart (2001) 0.96
Cognitive-behavioral therapy for noncardiac chest pain: a randomized trial. Am J Med (1999) 0.96
Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol (2000) 0.96
Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol (1993) 0.96
LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation (1996) 0.95
Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine. J Clin Endocrinol Metab (1977) 0.95
Original scientific reports. Results of operative treatment of 615 patients with primary hyperparathyroidism. World J Surg (1981) 0.94
Within-subject electrocardiographic differences at equal heart rates: role of the autonomic nervous system. Pflugers Arch (2001) 0.94
Adjacent genes, for COL2A1 and the vitamin D receptor, are associated with separate features of radiographic osteoarthritis of the knee. Arthritis Rheum (2000) 0.94
Bromocriptine in Nelson's syndrome and Cushing's disease. Lancet (1976) 0.94
Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease. JAMA (1979) 0.94
Bilateral cardiac myxomas and peripheral myxomas in a patient with recent myocardial infarction. Am J Cardiol (1979) 0.94
The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly. Eur J Clin Invest (1982) 0.94
The importance of pituitary tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour. Clin Endocrinol (Oxf) (1980) 0.93
Exercise test, history, and serum lipid levels in patients with chest pain and normal electrocardiogram at rest: comparison to findings at coronary arteriography. Am Heart J (1971) 0.92
Comparison of rigid and flexible rings for annuloplasty of the porcine mitral valve. Circulation (1990) 0.92
Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb (1991) 0.92
Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. J Lipid Res (1991) 0.92
Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. A plea for core laboratories. Int J Card Imaging (1996) 0.92
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol (1999) 0.92
The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab (1980) 0.91
Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis (1998) 0.91